Related references
Note: Only part of the references are listed.SpliceVault predicts the precise nature of variant-associated mis-splicing
Ruebena Dawes et al.
NATURE GENETICS (2023)
Drug Discovery Perspectives of Antisense Oligonucleotides
Yeonjoon Kim
BIOMOLECULES & THERAPEUTICS (2023)
Drugging p53 in cancer: one protein, many targets
Ori Hassin et al.
NATURE REVIEWS DRUG DISCOVERY (2023)
Development of drugs targeting hypoxia‐inducible factor against tumor cells with VHL mutation: Story of 127 years
Hajime Takamori et al.
CANCER SCIENCE (2023)
Therapeutic approaches for Duchenne muscular dystrophy
Thomas C. Roberts et al.
NATURE REVIEWS DRUG DISCOVERY (2023)
ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth
Wai Kit Ma et al.
CANCER RESEARCH (2022)
Systematic identification of intron retention associated variants from massive publicly available transcriptome sequencing data
Yuichi Shiraishi et al.
NATURE COMMUNICATIONS (2022)
Nonsense-mediated RNA decay: an emerging modulator of malignancy
Kun Tan et al.
NATURE REVIEWS CANCER (2022)
Drugging undruggable genes for cancer treatment: Are we making progress?
Michael J. Duffy et al.
INTERNATIONAL JOURNAL OF CANCER (2021)
Antisense oligonucleotides: absorption, distribution, metabolism, and excretion
Mohammad Shadid et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2021)
GENCODE 2021
Adam Frankish et al.
NUCLEIC ACIDS RESEARCH (2021)
PFRED: A computational platform for siRNA and antisense oligonucleotides design
Simone Sciabola et al.
PLOS ONE (2021)
To NMD or Not To NMD: Nonsense-Mediated mRNA Decay in Cancer and Other Genetic Diseases
Fran Supek et al.
TRENDS IN GENETICS (2021)
Casimersen: First Approval
Matt Shirley
DRUGS (2021)
Recent Advances in Oligonucleotide Therapeutics in Oncology
Haoyu Xiong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The Challenges and Strategies of Antisense Oligonucleotide Drug Delivery
Maria Gagliardi et al.
BIOMEDICINES (2021)
NRAS mutant melanoma: Towards better therapies
Tijana Randic et al.
CANCER TREATMENT REVIEWS (2021)
eSkip-Finder: a machine learning-based web application and database to identify the optimal sequences of antisense oligonucleotides for exon skipping
Shuntaro Chiba et al.
NUCLEIC ACIDS RESEARCH (2021)
Somatic selection distinguishes oncogenes and tumor suppressor genes
Pramod Chandrashekar et al.
BIOINFORMATICS (2020)
Targeting NRAS-Mutant Cancers with the Selective STK19 Kinase Inhibitor Chelidonine
Ling Qian et al.
CLINICAL CANCER RESEARCH (2020)
Targeting theERGoncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer
Ling Li et al.
BRITISH JOURNAL OF CANCER (2020)
Review of precision cancer medicine: Evolution of the treatment paradigm
Apostolia M. Tsimberidou et al.
CANCER TREATMENT REVIEWS (2020)
Therapeutic Strategies for Duchenne Muscular Dystrophy: An Update
Chengmei Sun et al.
GENES (2020)
Advances in oligonucleotide drug delivery
Thomas C. Roberts et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Pathogenic impact of transcript isoform switching in 1,209 cancer samples covering 27 cancer types using an isoform-specific interaction network
Abdullah Kahraman et al.
SCIENTIFIC REPORTS (2020)
DORGE: Discovery of Oncogenes and tumoR suppressor genes using Genetic and Epigenetic features
Jie Lyu et al.
SCIENCE ADVANCES (2020)
Golodirsen for Duchenne muscular dystrophy
S. Anwar et al.
DRUGS OF TODAY (2020)
The current state and future directions of RNAi-based therapeutics
Ryan L. Setten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
Thazha P. Prakash et al.
NUCLEIC ACIDS RESEARCH (2019)
Targeting Oncogenic BRAF: Past, Present, and Future
Aubhishek Zaman et al.
CANCERS (2019)
Pan-cancer whole-genome analyses of metastatic solid tumours
Peter Priestley et al.
NATURE (2019)
The impact of nonsense-mediated mRNA decay on genetic disease, gene editing and cancer immunotherapy
Rik G. H. Lindeboom et al.
NATURE GENETICS (2019)
COSMIC: the Catalogue Of Somatic Mutations In Cancer
John G. Tate et al.
NUCLEIC ACIDS RESEARCH (2019)
Genome-wide isoform-level analysis reveals tumor-specific isoforms for lung adenocarcinoma diagnosis and prognosis
Hu Zhuhong et al.
CANCER GENETICS (2019)
Viltotarsen for the treatment of Duchenne muscular dystrophy
R. R. Roshmi et al.
DRUGS OF TODAY (2019)
Identifying Genes Whose Mutant Transcripts Cause Dominant Disease Traits by Potential Gain-of-Function Alleles
Zeynep Coban-Akdemir et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2018)
Muscular Dystrophies
John C. Carter et al.
CLINICS IN CHEST MEDICINE (2018)
Exon-skipping advances for Duchenne muscular dystrophy
Lucia Echevarria et al.
HUMAN MOLECULAR GENETICS (2018)
Precision oncology in the age of integrative genomics
Chandan Kumar-Sinha et al.
NATURE BIOTECHNOLOGY (2018)
The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers
Zbyslaw Sondka et al.
NATURE REVIEWS CANCER (2018)
COSMIC: somatic cancer genetics at high-resolution
Simon A. Forbes et al.
NUCLEIC ACIDS RESEARCH (2017)
Overcoming cellular barriers for RNA therapeutics
Steven F. Dowdy
NATURE BIOTECHNOLOGY (2017)
Eteplirsen in the treatment of Duchenne muscular dystrophy
Kenji Rowel Q. Lim et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Control of gene expression through the nonsense-mediated RNA decay pathway
Andrew Nickless et al.
CELL AND BIOSCIENCE (2017)
NMD Classifier: A reliable and systematic classification tool for nonsense-mediated decay events
Min-Kung Hsu et al.
PLOS ONE (2017)
RNA mis-splicing in disease
Marina M. Scotti et al.
NATURE REVIEWS GENETICS (2016)
Leveraging Rules of Nonsense-Mediated mRNA Decay for Genome Engineering and Personalized Medicine
Maximilian W. Popp et al.
CELL (2016)
Mechanism and regulation of the nonsense-mediated decay pathway
Nele Hug et al.
NUCLEIC ACIDS RESEARCH (2016)
Splice-switching antisense oligonucleotides as therapeutic drugs
Mallory A. Havens et al.
NUCLEIC ACIDS RESEARCH (2016)
Evaluating the evaluation of cancer driver genes
Collin J. Tokheim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Identifying cancer type specific oncogenes and tumor suppressors using limited size data
Ana B. Pavel et al.
JOURNAL OF BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (2016)
The TREAT-NMD DMD Global Database: Analysis of More than 7,000 Duchenne Muscular Dystrophy Mutations
Catherine L. Bladen et al.
HUMAN MUTATION (2015)
Systematic transcriptome analysis reveals tumor-specific isoforms for ovarian cancer diagnosis and therapy
Christian L. Barrett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
VHL, the story of a tumour suppressor gene
Lucy Gossage et al.
NATURE REVIEWS CANCER (2015)
TP53 Mutations in Human Cancer: Database Reassessment and Prospects for the Next Decade
Bernard Leroy et al.
HUMAN MUTATION (2014)
Drugging the undruggable RAS: Mission Possible?
Adrienne D. Cox et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
SpliceAid 2: A Database of Human Splicing Factors Expression Data and RNA Target Motifs
Francesco Piva et al.
HUMAN MUTATION (2012)
ViennaRNA Package 2.0
Ronny Lorenz et al.
ALGORITHMS FOR MOLECULAR BIOLOGY (2011)
Loss of exon identity is a common mechanism of human inherited disease
Timothy Sterne-Weiler et al.
GENOME RESEARCH (2011)
Spliceosome Structure and Function
Cindy L. Will et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Coding potential of the products of alternative splicing in human
Guido Leoni et al.
GENOME BIOLOGY (2011)
PICMI: mapping point mutations on genomes
Loredana Le Pera et al.
BIOINFORMATICS (2010)
RNAstructure: software for RNA secondary structure prediction and analysis
Jessica S. Reuter et al.
BMC BIOINFORMATICS (2010)
The ubiquitin-proteasome system and nonsense-mediated mRNA decay in hypertrophic cardiomyopathy
Lucie Carrier et al.
CARDIOVASCULAR RESEARCH (2010)
The landscape of somatic copy-number alteration across human cancers
Rameen Beroukhim et al.
NATURE (2010)
Subtle variations in Pten dose determine cancer susceptibility
Andrea Alimonti et al.
NATURE GENETICS (2010)
SpliceAid: a database of experimental RNA target motifs bound by splicing proteins in humans
Francesco Piva et al.
BIOINFORMATICS (2009)
Human Splicing Finder: an online bioinformatics tool to predict splicing signals
Francois-Olivier Desmet et al.
NUCLEIC ACIDS RESEARCH (2009)
Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
Ben Langmead et al.
GENOME BIOLOGY (2009)
Antisense-mediated exon skipping: A versatile tool with therapeutic and research applications
Annemieke Aartsma-Rus et al.
RNA (2007)
OligoCalc: an online oligonucleotide properties calculator
Warren A. Kibbe
NUCLEIC ACIDS RESEARCH (2007)
Achieving targeted and quantifiable alteration of mRNA splicing with Morpholino oligos
Paul A. Morcos
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Entries in the Leiden Duchenne muscular dystrophy mutation database: An overview of mutation types and paradoxical cases that confirm the reading-frame rule
Annemieke Aartsma-Rus et al.
MUSCLE & NERVE (2006)
Improved antisense oligonucleotide induced exon skipping in the mdx mouse model of muscular dystrophy
CJ Mann et al.
JOURNAL OF GENE MEDICINE (2002)
WT1 proteins: functions in growth and differentiation
V Scharnhorst et al.
GENE (2001)
Share Paper
